PTI | New Delhi | Updated: 02-02-2021 14:46 IST | Created: 02-02-2021 14:21 IST
Representative image Image Credit: ANI
For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in an emergency situation by India s drug regulator, the Rajya Sabha was informed on Tuesday.
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalized a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines.
Advertisement
Covishield is being manufactured by the Pune-based firm with technology transfer from AstraZeneca/Oxford University.
Free COVID-19 vaccine for healthcare workers in first phase of vaccination: Choubey
SECTIONS
Last Updated: Feb 02, 2021, 03:54 PM IST
Share
Synopsis
A total of 165 lakh doses of COVID-19 vaccine have been procured of which 110 lakh doses are of Covishield vaccine manufactured by the Serum Institute of India and 55 lakh doses are of Covaxin vaccine manufactured by Bharat Biotech International Limited.
New Delhi: The COVID-19 vaccine is being provided free of cost to states and UTs for vaccination of healthcare and frontline workers in the first phase of vaccination, Minister of State for Health Ashwini Choubey informed Rajya Sabha on Tuesday. On whether any state has announced to supply the COVID-19 vaccine to the public free of cost including Kerala, Choubey said, The government of India has not received any formal communication from states and UT regarding announcement to supply the COVID-19 vaccine to the public free of cost, including Kerala.
3567 Commuters walk on a railway platform at CSMT as local train services resumed operations for general public after a gap of nearly ten months due to the coronavirus pandemic, in Mumbai. PTI Photo
New Delhi, February 2
The country is showing a declining trend of COVID-19 cases since the past four months and compared to similarly placed nations, the cases and deaths per million population in India is among the lowest, the government told Rajya Sabha on Tuesday.
Minister of State for Health Ashwini Choubey was responding to a question on the reasons for exponential multiplication of coronavirus cases in the country and whether there was a wrong approach at the initial stage by the government in focusing on testing, contact tracing, isolation and quarantine management.
Covishield s supply order placed after DCGI approval: Ashwini Choubey
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines
PTI | February 2, 2021 | Updated 15:20 IST
Serum Institute s Covishield and Bharat Biotech s Covaxin have been approved by the DCGI for emergency use
For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in emergency situation by India s drug regulator, the Rajya Sabha was informed on Tuesday.
»Covid Vaccines Being Provided Free to States and UTs in First Phase, Ashwini Choubey Informs Rajya Sabha
1-MIN READ
Covid Vaccines Being Provided Free to States and UTs in First Phase, Ashwini Choubey Informs Rajya Sabha
File photo of Ashwini Kumar Choubey
On whether any state has announced to supply the COVID-19 vaccine to the public free of cost including Kerala, Choubey said, The government of India has not received any formal communication from states and UT regarding announcement to supply the COVID-19 vaccine to the public free of cost, including Kerala.
FOLLOW US ON:
The COVID-19 vaccine is being provided free of cost to states and UTs for vaccination of healthcare and frontline workers in the first phase of vaccination, Minister of State for Health Ashwini Choubey informed Rajya Sabha on Tuesday.